Health News

At The Medicine Shoppe® Pharmacies, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.


The “Change” Doesn’t Have to Be the End
Women often dread menopause, recounting the hot flashes and mood swings of their mothers. A new review offers some insight into what it really means to go through the "change of life."
Is a PET Scan the Right Option for You?
For cancer survivors, vigilance is a key part of remaining cancer free. But new evidence suggests one cancer detection tool is being overused — and that isn’t helping anyone.
Headache and IBS: A Potential Link
A relationship between headaches and irritable bowel syndrome (IBS)? Surprisingly, there may be one.
Weight Loss: A Little Could Do a Lot
For overweight patients, attempting to shed those extra pounds can be daunting. But even dropping a few can have profound health benefits, new evidence suggests.
Before Knee Replacement, This Surgery May Help
Getting surgery before a knee replacement may seem counterintuitive. But, for some patients, getting one type of surgery could be a cost-effective way to improve outcomes.
The Prevalence of PTSD in Teens
By now, bullying and cyberbullying are on many parents' minds. But just how common are these problems among teens?
In Spinal Cord Rehab, Timing Matters
The human brain and nervous system have considerable healing abilities. And that is critically important for patients with spinal cord injuries.
The Harms of Masked Hypertension in CKD
Masked hypertension might sound like an odd sort of Halloween costume, but it's actually pretty serious stuff.
A Potential New Use for Pioglitazone
Sometimes a medication used to treat one condition can also help with another. That might be the case with pioglitazone (brand name Actos).
FDA Expands Indication For Breast Cancer Rx
On February 19, 2016, the U. S. Food and Drug Administration approved palbociclib (IBRANCE Capsules, Pfizer, Inc.) in combination with fulvestrant for the treatment of women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.